Bronte Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Philip Morris
PM
|
+$10.7M |
| 2 |
General Mills
GIS
|
+$9.98M |
| 3 |
Herbalife
HLF
|
+$4.53M |
| 4 |
Sotera Health
SHC
|
+$4.34M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$4.19M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$2.09M |
| 2 |
BioNTech
BNTX
|
+$1.32M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 49.25% |
| 2 | Financials | 18.73% |
| 3 | Communication Services | 10.98% |
| 4 | Consumer Staples | 10.05% |
| 5 | Healthcare | 6.5% |
Similar funds
Bronte Capital Management's Q3 2021 Portfolio in Review
As of Q3 2021, Bronte Capital Management held 27 positions worth $1.37B, down 2.5% from $1.4B the previous quarter. Its ten largest holdings account for 89% of the portfolio.
Bronte Capital Management deployed $44.4M of net new capital in Q3 2021, opening 6 new positions and adding to 8 existing holdings. Its largest new stake was Philip Morris: 106,293 shares worth $10.1M.
By sector, the portfolio is most concentrated in Miscellaneous at 49% of assets, down from 52% a quarter earlier, followed by Financials and Communication Services.
On the sell side, the largest reduction was Berkshire Hathaway Class B, an estimated $2.09M trimmed.
- Bronte Capital Management's largest Q3 2021 buy was Philip Morris: 106,293 shares worth $10.1M.
- Bronte Capital Management added most to Herbalife in Q3 2021, an estimated $4.53M increase.
- Bronte Capital Management's biggest Q3 2021 reduction was Berkshire Hathaway Class B, cutting an estimated $2.09M.
- Bronte Capital Management's ten largest holdings make up 89% of its $1.37B portfolio in Q3 2021.
- Bronte Capital Management opened 6 new positions and closed 0 in Q3 2021.
- Bronte Capital Management's portfolio value fell 2.5% quarter-over-quarter to $1.37B.
Based on Bronte Capital Management's 13F filing for Q3 2021, filed 9 Nov 2021.